are the oral 17-alpha-alkylated anabolic steroids liver-safe?

updated

oral survival through first-pass metabolism is part of the pharmacology and part of the hepatic-risk problem.

verdict: liver-safe claim contradicted (label warnings and controlled human harm signals)

quick answer

no. Oxandrolone, methandienone, stanozolol, and oxymetholone are 17-alpha-alkylated oral androgens. Labels and controlled human studies document liver-enzyme elevations, cholestatic and neoplastic warnings, and dose-linked toxicity.

the evidence

the risk appears in primary human records. (supported)

Oxandrolone's burn trial recorded more marked ALT elevations than placebo. Oxymetholone trials recorded dose-linked liver-enzyme toxicity. Stanozolol produced major adverse lipid changes in a controlled crossover.

one compound's reputation does not erase its label. (gap)

Words such as mild, dry, or less androgenic are not liver-safety endpoints. Historical approval also does not mean current marketing or low risk.

combining oral records does not create a validated stack. (risk)

No controlled human trial establishes the safety of concurrent 17-alpha-alkylated oral compounds. Class overlap raises concern without supplying a protocol.

bottom line

different molecules and formulations have different records, but none earns a liver-safe label.

scores

  • human harm evidence: 90 · labels and randomized trials
  • class mechanism: 92 · 17-alpha alkylation and hepatic exposure
  • safe-margin proof: 4 · no zero-risk exposure established
  • marketing gap: 94 · mild and dry language hides organ risk

sources

  1. Oxandrin historical prescribing information. Human half-life and boxed warnings.
  2. Wolf SE et al. Journal of Burn Care and Research. 2006. PMID 16566555. Randomized severe-burn outcome trial.
  3. Freed DL et al. British Medical Journal. 1975. PMID 125133. Placebo-controlled methandienone study in experienced weightlifters.
  4. Thompson PD et al. JAMA. 1989. PMID 2915439. Controlled crossover lipid and hepatic-lipase study.
  5. FDA. Anadrol-50 prescribing information, NDA 016848. Historical label and boxed warnings.
  6. Schroeder ET et al. American Journal of Physiology Endocrinology and Metabolism. 2003. PMID 12388137. Older-men body-composition RCT.
  7. Hengge UR et al. HIV Clinical Trials. 2003. PMID 12815555. HIV-associated wasting randomized trial.

keep reading

claim checks

reptides grades the research record and cites the literature behind every call. research reference only; not medical advice.